Keyphrases
Apoptosis
66%
Prostate Cancer
55%
Randomized Placebo-controlled Trial
55%
Cardiomyocytes
36%
Novel Therapeutic Targets
36%
Phase II Trial
34%
Natural Products
34%
Prostate Radiotherapy
31%
Hypertrophy
30%
Myocytes
30%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
30%
Therapeutic Potential
30%
Ischemia-reperfusion Injury
28%
Bomedemstat
27%
Bromodomain
27%
Intravenous Vitamin C
27%
Docetaxel
27%
High Dose
27%
Endoplasmic Reticulum Stress (ER stress)
27%
Ryanodine Receptor
27%
Superoxide Dismutase 2 (SOD2)
27%
L6 Myoblasts
27%
Colonic Pseudo-obstruction
27%
Attenuation
27%
Recurrent Prostate Cancer
27%
Domain-domain Interaction
27%
Heart Disease
27%
Heart Failure Model
27%
Murine Heart
27%
Muscadine Grape Skin
27%
Grape Skin Extract
27%
Cardiac Dysfunction
27%
P53-dependent Apoptosis
27%
Clinical Trials
24%
No Significant Difference
22%
Placebo
22%
Unfolded Protein Response
22%
PSA Doubling Time
20%
Puma
19%
RyR2
18%
Heart Failure
18%
PSA Response
18%
Oxidative Stress Markers
15%
Cardiomyocyte Apoptosis
14%
Cardiac Hypertrophy
14%
Myocardial Infarction
14%
PSA Progression
13%
Pro-apoptotic
13%
Progression-free Survival
13%
Adverse Effects
12%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Placebo
55%
Castration Resistant Prostate Cancer
50%
Congestive Heart Failure
41%
Biological Marker
38%
Puma
35%
Phase II Trials
33%
Natural Product
33%
Pharmacodynamics
27%
Lysine
27%
Pharmacokinetics
27%
Ascorbic Acid
27%
Docetaxel
27%
Ischemia
27%
Grape
27%
Cardiovascular Disease
27%
PUMA Protein
27%
Malignant Neoplasm
22%
Clinical Trial
22%
Diseases
17%
Reperfusion Injury
16%
Progression Free Survival
15%
Brain Ischemia
13%
Nerve Degeneration
13%
Heart Infarction
13%
Heart Ventricle Hypertrophy
13%
Chaperone
13%
Preclinical Study
11%
Side Effect
10%
Aortic Constriction
8%
Protein P53
8%
Monotherapy
5%
Antiproliferative Activity
5%
Drug Resistance
5%
Histone
5%
Therapeutic Window
5%
Intestine Flora
5%
Microbiome
5%
Heart Ventricle Remodeling
5%
Androgen
5%
Roseburia
5%
Biochemistry, Genetics and Molecular Biology
Programmed Cell Death
74%
Cardiac Muscle Cell
65%
P53 Upregulated Modulator of Apoptosis
27%
Lipid
27%
Endoplasmic Reticulum Stress
27%
Phosphoinositide 3-Kinase
27%
N-Terminus
27%
Ryanodine Receptor
27%
Reperfusion
25%
Puma
16%
Unfolded Protein Response
15%
Protein Kinase B
15%
Ryanodine Receptor 2
9%
Cell Size
9%
Animal Model
9%
Leucine
9%
P53
8%
Protein Biosynthesis
7%
Reoxygenation
6%
Bcl-2 Family
6%
Phosphatase
6%
